Search

everythinglearnresearchcommunity

for

Search:↓

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

Aldactone effectively reduces hair thickness in women with excessive hair growth, both alone and with other treatments.

Spironolactone effectively makes hair shafts thinner in women with excessive hair growth.

PRP therapy can be effective for early-stage common hair loss, with most patients seeing improvement, but there are inconsistencies in treatment methods.

Bimatoprost is safe and effective for treating eyelash loss caused by chemotherapy.

Bleach baths with 0.005% hypochlorite help manage atopic dermatitis by affecting skin cells and reducing itchiness.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

Eyebrow hair transplants in patients with frontal fibrosing alopecia may look good at first but often lose the new hair after a few years.

Liver transplantation is a viable option for children with propionic acidemia, improving quality of life and diet, but does not remove all risks and long-term brain outcomes are uncertain.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

5% minoxidil foam effectively regrows hair in women, with postmenopausal women seeing the most improvement.

Chemical peels are effective and popular for treating men's skin issues, with some special considerations for their unique skin needs.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Treating epilepsy is complex, requiring careful drug choice and patient adherence to manage seizures and side effects.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Fractional resurfacing is safe and effective for certain skin conditions in Asian patients, but care must be taken to avoid skin pigmentation issues.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The document concludes that there is hope for future psychopharmacology research despite challenges in treating schizophrenia.

Microneedling helps reduce hair-pulling and promotes hair regrowth in trichotillomania patients.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Scalp cooling effectively reduces hair loss from chemotherapy.